Nervonik

Los Angeles, United States

Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.

$13.0M raised

Apr 2026

Series B

Top Investors

U.S. Venture PartnersLumira VenturesFoothill VenturesCorrelation VenturesElevage Medical Technologies

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nervonik raised?

Nervonik has raised $13.0M in total funding. The most recent round was Series B. The last funding was announced in April 2026.

Who are Nervonik's investors?

Nervonik's investors include U.S. Venture Partners, Lumira Ventures, Foothill Ventures, Correlation Ventures, Elevage Medical Technologies.

Where is Nervonik headquartered?

Nervonik is headquartered in Los Angeles, United States.

What does Nervonik do?

Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.

What stage is Nervonik at?

Nervonik is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 27, 2026.

MLA

"Nervonik — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/nervonik. Accessed June 3, 2026.

APA

VCBacked. (2026). Nervonik — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/nervonik

Wikipedia (cite web)

{{cite web |title=Nervonik — Funding & Investors |url=https://www.vcbacked.co/company/nervonik |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 27, 2026.